Martin Stephen, Lopez Anna Lena, Bellos Anna, Deen Jacqueline, Ali Mohammad, Alberti Kathryn, Anh Dang Duc, Costa Alejandro, Grais Rebecca F, Legros Dominique, Luquero Francisco J, Ghai Megan B, Perea William, Sack David A
Pandemic and Epidemic Diseases Department, World Health Organization, Geneva, Switzerland .
University of the Philippines Manila-National Institutes of Health, Manila, Philippines .
Bull World Health Organ. 2014 Dec 1;92(12):881-93. doi: 10.2471/BLT.14.139949. Epub 2014 Sep 29.
To describe and analyse the characteristics of oral cholera vaccination campaigns; including location, target population, logistics, vaccine coverage and delivery costs.
We searched PubMed, the World Health Organization (WHO) website and the Cochrane database with no date or language restrictions. We contacted public health personnel, experts in the field and in ministries of health and did targeted web searches.
A total of 33 documents were included in the analysis. One country, Viet Nam, incorporates oral cholera vaccination into its public health programme and has administered approximately 10.9 million vaccine doses between 1997 and 2012. In addition, over 3 million doses of the two WHO pre-qualified oral cholera vaccines have been administered in more than 16 campaigns around the world between 1997 and 2014. These campaigns have either been pre-emptive or reactive and have taken place under diverse conditions, such as in refugee camps or natural disasters. Estimated two-dose coverage ranged from 46 to 88% of the target population. Approximate delivery cost per fully immunized person ranged from 0.11-3.99 United States dollars.
Experience with oral cholera vaccination campaigns continues to increase. Public health officials may draw on this experience and conduct oral cholera vaccination campaigns more frequently.
描述并分析口服霍乱疫苗接种运动的特点;包括地点、目标人群、后勤保障、疫苗接种率及交付成本。
我们检索了PubMed、世界卫生组织(WHO)网站及Cochrane数据库,无日期及语言限制。我们联系了公共卫生人员、该领域专家及各国卫生部,并进行了针对性的网络搜索。
分析共纳入33份文件。越南这一个国家将口服霍乱疫苗接种纳入其公共卫生计划,在1997年至2012年间已接种约1090万剂疫苗。此外,1997年至2014年间,在全球16次以上的接种运动中已接种超过300万剂两种经WHO预认证的口服霍乱疫苗。这些接种运动既有预防性的,也有反应性的,且在不同条件下开展,如难民营或自然灾害期间。两剂疫苗的估计接种率在目标人群的46%至88%之间。每名完全免疫者的大致交付成本在0.11至3.99美元之间。
口服霍乱疫苗接种运动的经验不断增加。公共卫生官员可借鉴这一经验,更频繁地开展口服霍乱疫苗接种运动。